United States: Senate Committee Releases Report On Potential Stark Law Changes, Hearing Scheduled

On June 30, 2016, the Senate Finance Committee’s Republican staff issued a 20-page report discussing comments made by industry stakeholders after a December 2015 round-table on the future of the physician self-referral law, also known as the Stark law. Unless an exception is met, the Stark law prohibits physicians from referring patients to facilities in which they have an ownership interest or compensation arrangement. Originally targeting the overutilization of physician-owned clinical laboratories, the Stark law has expanded to prohibit the referral of a wide range of “designated health services.” The law’s complexity has created what one Fourth Circuit judge described as “a booby trap rigged with strict liability and potentially ruinous exposure.” This is compounded by the fact that, as noted in the staff report, the Stark Law has been enforced primarily through the False Claims Act (“FCA”), thus imposing treble damages and penalties on the amounts paid by Medicare from any prohibited referral.

But most would agree that the Stark law has been a booby trap for years. Two developments explain the Committee’s recent motivation.

First, there has been a recent increase in exceptionally high settlements against providers that have violated Stark’s byzantine requirements but who have not engaged in activity that negatively impacts patient care or the Medicare program. The exposure for such technical violations is magnified by the fact that even the most technical of violations can expose providers to FCA liability. The potential for “ruinous exposure” has only increased with the Department of Justice’s recent interim final rule that would double FCA penalties.

The second reason relates to the impediments that Stark places in the move away from fee-for-service reimbursement and towards alternative payment models (“APMs”). APMs such as the Medicare Shared Savings Program and the Bundled Payments for Care Improvement Initiative (“BPCI”) were implemented under the Affordable Care Act (“ACA”) to test reimbursement models other than Medicare’s traditional fee-for-service (“FFS”) model. The reliance on APMs to drive down health care costs increased dramatically with the passage of the Medicare Access and CHIP Reauthorization Act of 2015 (“MACRA”). Under MACRA, APMs have been transformed from mere pilot projects into driving forces for the abandonment of our FFS system. And as our fee-for-service system diminishes, so too does the primary reason for the Stark law. As the Committee notes in its report:

The risk of overutilization, which drove the passage of the Stark Law, is largely or entirely eliminated in alternative payment models. When physicians earn profit margins not by the volume of services but by the efficiency of services and treatment outcomes, their economic self-interest aligns with the interest to eliminate unnecessary services.

To help ensure that APM participants would not run afoul of the law, the ACA authorized the Secretary of Health and Human Services (HHS) to issue regulatory waivers of Stark and other fraud and abuse laws. These waivers have certainly encouraged providers to implement APMs. However, as the report notes, the waivers do not protect all of the APMs under MACRA, nor do they protect APMs that are implemented by commercial payers. With this in mind, the Committee invited participants to comment on the current Stark law environment, health care reform implementation, costs associated with compliance and disclosures, possible fixes under both FFS and alternative payment models, and CMS’ limited authority to create exceptions and to issue advisory opinions. The participants were also asked to specifically focus on (1) changes to the Stark law to implement health care reform, specifically MACRA, and (2) the distinction between technical and substantive violations.

Stakeholder Comments Related to Implementing MACRA

In its report, the Committee identified a number of common themes related to the Stark law and the implementation of MACRA, including the following:

  • Repealing Stark. The boldest suggestion is for a full repeal of the Stark law. These commenters argued that the federal anti-kickback statute (“AKS”) in its current form can address the conduct that the Stark law seeks to curtail.
  • Repealing the Compensation Arrangement Prohibitions. A slightly less bold suggestion is for the repeal of the Stark law’s compensation prohibition. As noted above, the Stark law prohibits referrals to entities in which the physician has an ownership and investment interest, or where the physician has a compensation arrangement with the entity. Many of the significant Stark settlements have related to compensation arrangements between hospitals and physicians. An elimination of this prohibition would undoubtedly go a long way to eliminating some of the complexity and the extreme exposure facing providers.
  • New Risk Revenue Waiver. Multiple commenters recommended creating a new waiver from the Stark law for health care entities that have risk-related revenue of a certain threshold.
  • Expansion of Existing Waivers; New Waivers. Most commenters suggested extending the waivers that are currently limited to CMS-run programs so that they apply to APMs of all payers. Many commenters believed that expanding the waivers for the MSSP to qualifying APM participants would be the best solution.
  • New Exceptions. Some commenters recommended creating a new exception to enable financial arrangements that involve risk-sharing and gainsharing in APMs when appropriate safeguards are in place. Other commenters believe that a new exception should be designed to foster collaboration in the delivery of health care, referring to integrated delivery systems, accountable care, team-based care, and value-based payment arrangements. Other commenters suggested the creation of a new Stark law exception that would apply to MIPS, physician-focused payment models, and payments associated with APMs.
  • Special Compensation Rule. A majority of comments touched on potential changes to how the Stark law treats compensation arrangements. One commenter suggested a special compensation rule related to MACRA alternative payment model financial arrangements that would automatically deem such arrangements (1) not to take into account the volume or value of referrals, or other business generated between the parties, and (2) constitute fair market value, provided all MACRA alternative payment model programmatic requirements are otherwise met.
  • Modify Existing Exceptions. Commenters also suggested modifying existing statutory or regulatory exceptions. For example, several comments recommended that Congress expand the Stark law’s risk-sharing exception to apply to Medicare. Others suggested a new exception be created based on the risk-sharing exception that would apply to the various models implemented by the Center for Medicare & Medicaid Innovation (“CMMI”), including the MSSP, the Pioneer and Next Generation ACO models, and other CMMI models, as long as the arrangement is reasonably related to one of the purposes of the respective program.
  • Broadening CMS’ Regulatory Authority. Many commenters agreed not only that Congress should create waivers but also that Congress should give CMS broader authority to create regulatory waivers.

Stakeholder Comments Unrelated to Implementing MACRA

Comments not related to MACRA included changes to Stark law’s definitions, including the definition of “fair market value,” “the volume or value of referrals,” and “commercial reasonableness.” On the issue of distinguishing between technical and substantive violations, many comments focused on documentation requirements and whether or not the violations harmed beneficiaries or federal health care programs. Commenters generally agreed that technical violations should be subject to a separate set of sanctions that would not give rise to either FCA exposure or potentially ruinous repayment liability. Some commenters submitted other suggestions for improving the law, including changes or clarifications to the in-office ancillary services exception, the physician-owned hospital exception, and documentation requirements.


Historically, Congress has had little appetite to revise legislation like the Stark law that is seen as combating fraudulent or abusive arrangements. However, the Committee is clearly concerned that the extremely broad law, with its extraordinarily harsh penalties, may prove to be an obstacle to implementing core parts of MACRA. While there is nothing to indicate that revisions to the Stark law are imminent, the Committee’s report is a positive development, and suggests that at least some members of Congress are seriously considering reforming the Stark law. The Committee will be holding a hearing on this issue on July 12, 2016.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Rodney L. Whitlock
In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement

Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of www.mondaq.com

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at enquiries@mondaq.com.

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.